Accepted for Publication: April 18, 2013.
Published Online: October 28, 2013. doi:10.1001/jamaneurol.2013.3205.
Study concept and design: Thomas, Fadul.
Acquisition of data: Rauschkolb, Gresa-Arribas, Schned.
Analysis and interpretation of data: Schned, Dalmau, Fadul.
Drafting of the manuscript: Thomas, Gresa-Arribas, Fadul.
Critical revision of the manuscript for important intellectual content: Rauschkolb, Schned, Dalmau, Fadul.
Administrative, technical, or material support: Gresa-Arribas, Schned, Dalmau.
Study supervision: Schned, Dalmau, Fadul.
Conflict of Interest Disclosures: Dr Dalmau has received a research grant from EUROIMMUN and receives royalties from patents for the use of Ma2 and NMDAR as an autoantibody test. No other disclosures were reported.
Funding/Support: This work was supported in part by National Institutes of Health grant RO1NS077851, Fundació la Marató TV3, and Fondo de Investigaciones Sanitarias grant PI11/01780 (Dr Dalmau).
Role of the Sponsor: The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.